allowing a separation of patients with biochemically and surgically confirmed primary aldosteronism from the other group was the plasma aldosterone-plasma renin activity ratio. The present study therefore confirms the diagnostic value of this ratio for identifying patients with primary aldosteronism.
As hypokalaemia along with hypertension are the cardinal signs of primary aldosteronism (PA), serum potassium determinations have been wide¬ ly used to identify this condition. A variety of tests have been developed to help diagnosing primary aldosteronism, such as the infusion of saline (Kern et al. 1971) or the administration of a mineralo¬ corticoid (Horton 1969 however, appeared to be relatively small. In five cases of PA, an overlap with the other group of patients was registered. The plasma levels of aldosterone varied widely in the study population within the range of 1.0 -275 ng/100 ml. As can be seen from Fig. 2 (Fig. 3) .
The PRA values did not separate 6 PA patients from the other group.
The plasma aldosterone-plasma renin activity ratio (A-PRA) separated the two groups entirely (Fig. 4) (Conn et al. 1974) . The traditional approach to PA has long been to suspect the Plasma aldosterone-plasma renin activity ratio in the study population. For details, see Fig. 1 (1 pkat/l corresponds to the consumption of 1 pmol of substrate per second).
syndrome only in patients with overt hypokalae¬ mia. There is reason to believe that such an attitude to the problem may explain why the disorder often escapes identification for long per¬ iods although the patients are under medical supervision. Firstly, normokalaemia is well docu¬ mented in PA patients (Streeten et al. 1979) , and as many as 25% of the APA patients from the Cleveland Clinic had normal serum potassium levels at diagnosis (Bravo et al. 1983 
